Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marion Schuller

Showing results (1-10 of 31) with videos related to

Pageof 4
Sort By:
The Biochemical Journal|February 17, 2022
Beyond protein modification: the rise of non-canonical ADP-ribosylationMarion Schuller, Ivan Ahel
Chemmedchem|August 5, 2017
Simultaneous Multiple MS Binding Assays Addressing D<sub>1</sub> and D<sub>2</sub> Dopamine ReceptorsMarion Schuller, Georg Höfner, Klaus T Wanner
Toxins|May 24, 2024
Specificity of DNA ADP-Ribosylation Reversal by NADARsBara Cihlova, Yang Lu, Andreja Mikoč, et al.
Microbiology (Reading, England)|July 29, 2024
Aspartate aminotransferase of <i>Rhizobium leguminosarum</i> has extended substrate specificity and metabolizes aspartate to enable N<sub>2</sub> fixation in pea nodulesRaphael Ledermann, Alexandre Bourdès, Marion Schuller, et al.
Open Biology|November 17, 2020
Viral macrodomains: a structural and evolutionary assessment of the pharmacological potentialJohannes Gregor Matthias Rack, Valentina Zorzini, Zihan Zhu, et al.
Toxins|February 26, 2026
ADP-Ribosylation of Cytidine: A Novel Nucleic Acid Modification Reversed by NADAR HydrolasesPetra Mikolčević, Andrea Hloušek-Kasun, Marion Schuller, et al.
Nucleic Acids Research|July 12, 2025
Regulation of a phage defence island by RptR, a novel repressor that controls restriction-modification systems in diverse bacteriaYuGeng Zhang, Marion Schuller, Ivan Ahel, et al.
Nucleic Acids Research|February 19, 2025
Discovery of reversing enzymes for RNA ADP-ribosylation reveals a possible defence module against toxic attackYang Lu, Marion Schuller, Nathan P Bullen, et al.
Nucleic Acids Research|February 18, 2025
Discovery of reversing enzymes for RNA ADP-ribosylation reveals a possible defence module against toxic attackYang Lu, Marion Schuller, Nathan P Bullen, et al.
Pathogens (Basel, Switzerland)|February 25, 2023
Discovery and Development Strategies for SARS-CoV-2 NSP3 Macrodomain InhibitorsMarion Schuller, Tryfon Zarganes-Tzitzikas, James Bennett, et al.
Pageof 4

Showing results (1-10 of 31) with videos related to

Sort By:
Pageof 4
The Biochemical Journal|February 17, 2022
Beyond protein modification: the rise of non-canonical ADP-ribosylationMarion Schuller, Ivan Ahel
Chemmedchem|August 5, 2017
Simultaneous Multiple MS Binding Assays Addressing D<sub>1</sub> and D<sub>2</sub> Dopamine ReceptorsMarion Schuller, Georg Höfner, Klaus T Wanner
Toxins|May 24, 2024
Specificity of DNA ADP-Ribosylation Reversal by NADARsBara Cihlova, Yang Lu, Andreja Mikoč, et al.
Microbiology (Reading, England)|July 29, 2024
Aspartate aminotransferase of <i>Rhizobium leguminosarum</i> has extended substrate specificity and metabolizes aspartate to enable N<sub>2</sub> fixation in pea nodulesRaphael Ledermann, Alexandre Bourdès, Marion Schuller, et al.
Open Biology|November 17, 2020
Viral macrodomains: a structural and evolutionary assessment of the pharmacological potentialJohannes Gregor Matthias Rack, Valentina Zorzini, Zihan Zhu, et al.
Toxins|February 26, 2026
ADP-Ribosylation of Cytidine: A Novel Nucleic Acid Modification Reversed by NADAR HydrolasesPetra Mikolčević, Andrea Hloušek-Kasun, Marion Schuller, et al.
Nucleic Acids Research|July 12, 2025
Regulation of a phage defence island by RptR, a novel repressor that controls restriction-modification systems in diverse bacteriaYuGeng Zhang, Marion Schuller, Ivan Ahel, et al.
Nucleic Acids Research|February 19, 2025
Discovery of reversing enzymes for RNA ADP-ribosylation reveals a possible defence module against toxic attackYang Lu, Marion Schuller, Nathan P Bullen, et al.
Nucleic Acids Research|February 18, 2025
Discovery of reversing enzymes for RNA ADP-ribosylation reveals a possible defence module against toxic attackYang Lu, Marion Schuller, Nathan P Bullen, et al.
Pathogens (Basel, Switzerland)|February 25, 2023
Discovery and Development Strategies for SARS-CoV-2 NSP3 Macrodomain InhibitorsMarion Schuller, Tryfon Zarganes-Tzitzikas, James Bennett, et al.
Pageof 4